TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/24/25 17:52 | 2/24/25 | CLSD | Clearside Biomedical, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Thorp Clay | GA | D | P | 14 | 0.9200 | 0 | 15 | 9 | 176 | D | |||||||||||||||
9/25/23 16:34 | 9/25/23 | CLSD | Clearside Biomedical, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Thorp Clay | GA | D | P | 9 | 0.8600 | 0 | 10 | 0 | 3,586 | D | |||||||||||||||
5/19/23 16:18 | 5/19/23 | PHAS | Phasebio Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Thorp Clay | DE | D | M.d | 0 | 0.00 | 0 | 4 | 0 | 3,582 | D | |||||||||||||||
12/21/22 16:26 | 12/21/22 | CLSD | Clearside Biomedical, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Thorp Clay | GA | D | P | 14 | 1.02 | 0 | 14 | 0 | 3,576 | D | |||||||||||||||
12/19/22 19:40 | 2/10/21 | CLSD | Clearside Biomedical, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Thorp Clay | GA | D | S.a | -146 | 4.43 | 0 | -33 | -1 | 4,952 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |